Familial avascular necrosis of the femoral head

From WikiMD's WELLNESSPEDIA

Alternate names[edit]

Familial osteonecrosis of the femoral head; Primary avascular necrosis of the femoral head

Definition[edit]

Avascular necrosis of the femoral head (ANFH) is a degenerative condition which causes the upper ends of the thigh bones (femurs) to break down due to a disrupted blood supply and poor bone repair.

  • It can lead to pain and limping, hip collapse, and cause the legs to be of unequal length.
  • In children, ANFH is known as Legg-Calves-Perthes disease.

Epidemiology[edit]

  • Around 20,000-30,000 cases are reported each year in the United States.
  • This condition mainly affects young, active adults, but can occur in children as well.

Cause[edit]

  • Although rare, there are some families that have an inherited form of ANFH.
  • Genetic changes in the type II collagen gene (COL2A1) cause ANFH in a few families.
  • This gene is responsible for making a protein that helps build cartilage.
  • One other family was found to have a genetic change in the transient receptor potential vanilloid 4 gene (TRPV4).
  • This gene makes a protein that helps regulate blood flow.

In the non-inherited types of avascular necrosis of the femoral head, the cause is not clear.

These are some of the factors have been associated with an increased chance to get ANFH:

ANFH can also develop in a person who has had a hip injury (like a fracture or dislocation) or hip surgery.

Inheritance[edit]

Autosomal dominant pattern, a 50/50 chance.

Most cases of avascular necrosis of the femoral head (ANFH) are not inherited in families. In a few rare families, ANFH is inherited in an autosomal dominant pattern.

Signs and symptoms[edit]

  • In the early stages, avascular necrosis of the femoral head does not cause any symptoms.
  • As the bone damage increases, people may have leg and hip pain, a limited ability to move the leg, and a limp.
  • Some people may develop a difference in the length of their legs.
  • Eventually, the hip joint breaks down and surgery may be required.

For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. 80%-99% of people have these symptoms

30%-79% of people have these symptoms

  • Flattened femoral head(Flat head of thigh bone)
  • Hip osteoarthritis
  • Hip pain
  • Impairment of activities of daily living
  • Limited hip movement
  • Lower limb asymmetry(Left and right leg differ in length or width)
  • Short stepped shuffling gait(Short stepped shuffling walk)

5%-29% of people have these symptoms

Diagnosis[edit]

  • Avascular necrosis of the femoral head is diagnosed based the symptoms, and by using imaging, such as X-rays or MRI.
  • A physical examination can be helpful as well.
  • People with the familial (inherited) form of ANFH may have other family members with the same condition.

Treatment[edit]

  • Treatment for avascular necrosis of the femoral head may depend on how early it is diagnosed and the presence of an underlying condition.
  • It is not clear if medications are helpful.
  • Surgery may help in some cases.
  • In the more advanced stages, total hip replacement is an option.

Prognosis[edit]

The long-term outlook for avascular necrosis of the femoral head depends on the stage that it is diagnosed. Most people with this condition will end up having arthritis in the joint as well as hip collapse. Children diagnosed with this condition have a better long term outlook than adults.

NIH genetic and rare disease info[edit]

Familial avascular necrosis of the femoral head is a rare disease.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.